Evidence map›Paper›PMID 31249987›Full record

ArticleTH open : companion journal to thrombosis and haemostasis2019

Patient Management Strategies and Long-Term Outcomes in Isolated Distal Deep-Vein Thrombosis versus Proximal Deep-Vein Thrombosis: Findings from XALIA.

Walter Ageno, Lorenzo G Mantovani, Sylvia Haas, Reinhold Kreutz, Danja Monje, Jonas Schneider, Jörg-Peter Bugge, Martin Gebel, Alexander G G Turpie

Abstract read
In one paragraph

Article in TH open : companion journal to thrombosis and haemostasis, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Anticoagulation Duration After First Venous Thromboembolism: Real-Life Data From the International, Observational WHITE Study.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Walter AgenoDepartment of Medicine and Surgery, University of Insubria, Varese, Italy.
Lorenzo G MantovaniCESP-Center for Public Health Research, University of Milano-Bicocca, Monza, Italy.
Sylvia HaasFormerly Institute for Experimental Oncology and Therapy Research, Technical University of Munich, Munich, Germany.
Reinhold KreutzCharité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany.
Danja MonjeBayer AG, Berlin, Germany.
Jonas SchneiderBayer AG, Berlin, Germany.
Jörg-Peter BuggeBayer AG, Berlin, Germany.
Martin GebelBayer AG, Wuppertal, Germany.
Alexander G G TurpieDepartment of Medicine, Hamilton Health Sciences, Hamilton, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

deep-vein thrombosisrivaroxabanroutine clinical practicevenous thromboembolism

Identifiers

PMID31249987
PMCPMC6524913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.